GWAS |
- Estimated glomerular filtration rate ( 31152163)
- Response to tofacitinib treatment (herpes zoster) ( 33455090)
- Response to tofacitinib treatment (herpes zoster)(time to event) ( 33455090)
- Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster) ( 33455090)
- Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event) ( 33455090)
|
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Bipolar disorder ( 31043756)
- Bitter alcoholic beverage consumption ( 31046077)
- Body mass index ( 26426971)
- General risk tolerance (MTAG) ( 30643258)
- Refractive error ( 32231278)
- Schizophrenia ( 25056061 29483656)
- Triglycerides ( 30275531)
|